IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#4673
Positioning
Market Dominance
Mining
Non-Metallic And Industrial Metal Mining
$544M
Chris Showalter
Lifezone Metals Limited operates as a metals company in the battery metals supply chain of extraction, processing, and recycling. It supplies low-carbon and sulphur dioxide emission metals to the battery and EV markets. The company's products include nickel, copper, and cobalt. Its flagship project is the Kabanga nickel project in North-West Tanzania. The company is based in Ramsey, Isle of Man.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$VALE Vale S.A. | 75 | 88 | 93 | 67 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$SU SUNCOR ENERGY INC | 74 | 87 | 90 | 53 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$TRX TRX GOLD Corp | 72 | 83 | 77 | 96 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$ORLA Orla Mining Ltd. | 72 | 94 | 83 | 78 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$KGC KINROSS GOLD CORP | 71 | 83 | 89 | 79 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$AEM AGNICO EAGLE MINES LTD | 71 | 80 | 80 | 71 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$RIO RIO TINTO PLC | 70 | 76 | 84 | 64 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$IAG IAMGOLD CORP | 70 | 71 | 82 | 89 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$NGD New Gold Inc. /FI | 70 | 76 | 67 | 92 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$PDS PRECISION DRILLING Corp | 70 | 77 | 90 | 65 | - | - | - | - | - | - | - | - | - | - | $0 | VS | |
$LZM Lifezone Metals Ltd | 27 | 16 | 16 | 21 | - | - | -167.9% | -96.0% | 38.2% | -34353.8% | -26739.9% | -90.5% | 0.0% | 30.0x | $544M | ||
| SECTOR BENCH | - | - | - | - | - | 13.7x | 5.2x | 4.3% | 3.9% | 45.8% | 7.6% | 5.8% | 0.1% | 0.0% | 0.3x | - | REF |
Lifezone Metals Ltd (LZM) receives a "Avoid" rating with a composite score of 27.4/100. It ranks #4673 out of 7,333 stocks in our coverage universe and carries a 1-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
No analyst ratings for LZM.
View All RatingsVerified SEC Filings Aggregate • LZM
Direct unfiltered access to 10-K, 10-Q and 8-K filings for LZM.
Open Regulatory DossierFigures adjusted for stock splits and restatements where applicable.
TTM (Trailing Twelve Months) data updates within 48 hours of quarterly filings.
YOY expansion rate
Core pricing power
Operating efficiency
Equity efficiency
Financial leverage
Direct cash return
Lagging peers — losers tend to keep underperforming
Expensive relative to fundamentals — limited margin of safety
Weak fundamentals — higher risk of value trap
High volatility — wider range of outcomes increases timing risk
Moderate investment profile
Below-average composite — caution warranted
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 16 | 4 | +12ALPHA |
| MOMENTUM | 21 | 13 | +8ALPHA |
| VALUATION | 16 | 9 | +7ALPHA |
| INVESTMENT | 46 | 73 | -27DRAG |
| STABILITY | 33 | 25 | +8ALPHA |
| SHORT INT | 38 | 30 | +8ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy -167.9% (sector 4.3%)
GM 38% vs sector 46%, OM -34354% vs sector 8%
Capital turnover N/A
Rev growth -90%, 2yr history
Interest coverage N/A
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
We rate Lifezone Metals Ltd (LZM) as Avoid with a composite score of 27.4/100 at a current price of $4.21. The stock falls in the bottom quintile, and the multi-factor weakness suggests a high probability of continued underperformance.
Lifezone Metals Ltd holds a top-quartile position (#0 of 50) within the Mining sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 27.4/100 places it at rank #4673 in our full universe.
No Moat
High
Poor
Fair Value
Stable competitive position in a defensive sector.
Weak momentum suggests persistent institutional selling pressure.
Below-average quality raises earnings sustainability concerns.
Vulnerability to macroeconomic shocks and interest rate volatility.
Lifezone Metals Ltd represents a avoid based on multi-factor quantitative performance.
Our quantitative model flags Lifezone Metals Ltd with an Avoid rating, assigning a composite score of 27.4/100 and 1 out of 5 stars. Ranked #4673 of 7,333 stocks, LZM falls in the bottom tier across key factors. Historically, stocks with this profile have faced elevated risk of underperformance and capital loss.
Lifezone Metals Ltd registers a weak quality score of just 16/100, indicating significant profitability challenges. The company reports a return on equity of -167.9% (sector avg: 4.3%), gross margins of 38.2% (sector avg: 45.8%), net margins of -26739.9% (sector avg: 5.8%). Low quality scores are often associated with businesses in turnaround mode, early-stage growth, or structurally challenged industries.
LZM registers a value score of just 16/100, suggesting the stock trades at a significant premium to its fundamental metrics. Key valuation metrics include a P/B ratio of 3.92x. High-premium valuations like this require strong future execution to avoid multiple compression, and downside risk is elevated if growth disappoints.
With an investment score of 46/100, LZM exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of -90.5% vs. a sector average of 0.1% and a return on assets of -96.0% (sector: 3.9%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
Lifezone Metals Ltd is experiencing notably weak momentum with a score of just 21/100. The stock has underperformed its peers and is trending below major moving averages. Revenue growth stands at -90.5% year-over-year, while a beta of 0.79 reflects its sensitivity to broader market moves. While deep momentum weakness can occasionally present value opportunities, it often reflects deteriorating fundamentals or structural headwinds that may persist.
LZM's stability score of 33/100 signals elevated volatility and/or leverage concerns. Key stability metrics include a beta of 0.79 and a debt-to-equity ratio of 30.00x (sector avg: 0.3x). Investors should be prepared for wider-than-average price swings and consider position sizing accordingly to manage portfolio risk.
Lifezone Metals Ltd's short interest score of 38/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 30.00x), small-cap liquidity risk. At $544M (small-cap), LZM carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
Lifezone Metals Ltd is a small-cap company in the Mining sector, ranked #0 of 50 in its sector (100th percentile) and #4673 of 7,333 overall (36th percentile). Key comparisons include ROE of -167.9% trailing the 4.3% sector median and operating margins of -34353.8% below the 7.6% sector average. This top-quartile standing reflects exceptional competitive strength relative to Mining peers.
While LZM currently exhibits a AVOID profile, superior opportunities exist within the MINING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Mining Alpha →Quant Factor Profile
Upgrade catalyst
Improvement in Quality (16) would have the largest impact on the composite score.
ROE 4004% BELOW SECTOR MEDIAN
Gross Margin 17% BELOW SECTOR MEDIAN
Op. Margin 453915% BELOW SECTOR MEDIAN
Relative to Mining Median (N=253)
Relative valuation derived from Mining sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Synthesized from recent 13F filings, Form 4 insider transactions, and outstanding short interest metrics.
Lower quality and stability scores may indicate governance concerns. Verified against factor-based integrity benchmarks.
No recent insider transactions available for LZM
Institutional cap table data requires verified 13F filing feeds.
Access SEC 13F Dossier →Insider transaction data currently awaiting regulatory verification.
Access SEC Form 4 Dossier →Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Above 50MA
37.18%
Net New Highs
+51081
Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share. TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday. Here are some other stocks moving in today's mid-day session. Gainers Charge Enterprises, Inc. (NASDAQ: CRGE) shares surged 105.4% to $0.2510. Kaman Corporation (NASDAQ: KAMN) shares climbed 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion. Mesa Air Group Inc (NASDAQ: MESA) gained 70.4% to $1.09 as the company entered into new agreements with United Airlines for improved operating and financing terms. Edgewise Therapeutics, Inc. (NASDAQ: EWTX) rose 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share. Processa Pharmaceuticals, Inc. (NASDAQ: PCSA) climbed 34.2% to $0.2725. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer. Tricon Residential Inc. (NYSE: TCN) shares gained 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash. Spirit Airlines, Inc. (NYSE: SAVE) jumped 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue "remains in full force and effect." Super Micro Computer, Inc. (NASDAQ: SMCI) climbed 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook. Allied Gaming & Entertainment Inc. (NASDAQ: AGAE) rose 20.6% to $1.1190. Portage Biotech Inc. (NASDAQ: PRTG) gained 19% to $1.14. ProMIS Neurosciences, Inc. (NASDAQ: PMN) ...
U.S. stocks traded lower, with the Nasdaq Composite falling more than 1% on Wednesday. Here are some big stocks recording gains in today’s session. Scholar Rock Holding Corporation (NASDAQ: SRRK) shares jumped 16.5% to $8.92. Jefferies upgraded Scholar Rock from Hold to Buy and announced a $20 price target. Stride, Inc. (NYSE: LRN) climbed 16.4% to $51.81 after the company reported first-quarter results. GH Research PLC (NASDAQ: GHRS) gained 9.8% to $7.59. PROG Holdings, Inc. (NYSE: PRG) rose 9.3% to $31.14 following upbeat quarterly results. Anavex Life Sciences Corp. (NASDAQ: AVXL) gained 9% to $5.59. Anavex Life Sciences reported a new publication in a scientific journal demonstrating the potential of ANAVEX 3-71 ...
Gainers Blue Apron Holdings, Inc. (NASDAQ: APRN) climbed 133.5% to $12.82 after the company announced an agreement to be acquired by Wonder Group for $13 per share. OpGen, Inc. (NASDAQ: OPGN) shares jumped 109% to $0.4201 after the company requested to withdraw its registration statement on Form S-1. Novo Integrated Sciences, Inc. (NASDAQ: NVOS) shares gained 66.3% to $0.3343 after the company announced it signed a One Billion Dollar Master Collateral Transfer Agreement with Blacksheep Trust for the purpose and general use of monetization for a period of up to 15 years. CF Acquisition Corp. VIII (NASDAQ: CFFE) gained 61% to $29.51. Femasys Inc. (NASDAQ: FEMY) surged 48% to $2.2650 after HC Wainwright maintained a Buy rating on the stock and raised its price target from $5 to $13. RVL Pharmaceuticals plc (NASDAQ: RVLP) shares climbed 35.7% to $0.1060. SeaStar Medical Holding Corporation (NASDAQ: ICU) gained 35% to $0.2528 after the company announced it was granted Breakthrough Device Designation by the FDA for its Selective Cytopheretic Device for Cardiorenal Syndrome. Structure Therapeutics Inc. (NASDAQ: GPCR) shares climbed 31.6% to $49.30 after the company announced results from its Phase 1b clinical study of oral GLP-1 receptor agonist GSBR-1290 and provided a program update. T2 Biosystems, Inc. (NASDAQ: TTOO) rose 26.6% to $0.2258. Starbox Group Holdings Ltd. (NASDAQ: STBX) surged 22.8% to $1.0252. Capstone Green Energy Corporation (NASDAQ: CGRN) gained 20% to $0.60. Evolve Transition Infrastructure LP (NYSE: SNMP) jumped 19% to $1.6312. Velo3D, Inc. ...
U.S. stocks traded higher, with the Nasdaq Composite gaining around 1% on Friday. Here are some big stocks recording losses in today’s session. Corcept Therapeutics Incorporated (NASDAQ: CORT) shares fell 21% to $26.07. Lifezone Metals Limited (NYSE: LZM) shares tumbled 15.7% to $13.05. Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) fell 15% to $13.29. JP Morgan maintained Syndax Pharmaceuticals with an Overweight and lowered the price target from $36 to $33. Opera Limited (NASDAQ: OPRA) shares tumbled 11.3% to $11.57 after the company announced the pricing of its underwritten secondary public ...
Gainers FaZe Holdings Inc. (NASDAQ: FAZE) shares rose 64.7% to $0.2520 in pre-market trading after falling over 4% on Friday. Biophytis S.A. (NASDAQ: BPTS) shares rose 31.5% to $1.21 in pre-market trading. Biophytis and Skyepharma sign a partnership agreement for the production of Sarconeos (BIO101). Avalo Therapeutics, Inc. (NASDAQ: AVTX) shares gained 24% to $0.1478 in pre-market trading after gaining 16% on Friday. The company recently announced the sale of its assets relating to AVTX-801 (D-galactose), AVTX-802 (D-mannose) and AVTX-803 (L-fucose) on Sept. 12. Knightscope, Inc.. (NASDAQ: KSCP) gained 17.7% to $0.8780 in pre-market trading. E-Home Household Service Holdings Limited (NASDAQ: EJH) shares rose 17.2% to $1.10 in pre-market trading. Vapotherm, Inc. (NASDAQ: VAPO) shares jumped 9.8% to $2.70 in pre-market trading. Vapotherm, announced the presentation of an Investigator-initiated clinical trial, "High flow humidified oxygen as an early intervention in children with acute severe asthma - a feasibility ...